Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Neuromodulation of Craving Control for Meth Use Disorders

NCT06695637 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT06695637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06695637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Neuromodulation of Craving Control for Meth Use Disorders
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Withdrawn
Start date
September 1, 2025
Completion date
September 1, 2029
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorders, substance use disorders